All of us at one time or another  have received a prescription drug from a doctor. We almost take for granted that it’s the right drug for our treatment and that the pharmacist gives us the right drug when he or she fills the prescription.

Are you suffering from the adverse side effects of prescription drugs? Call Dawson & Albritton, PA today at 252-752-2485

Serious health problems result from prescription errors or when the prescribed drug reacts to other drugs we are taking in a way that adversely affects our health. This is called contraindication.  This includes drugs prescribed after surgeries and by other health care providers like counselors, physical therapists, psychologist and psychiatrists.

Dawson & Albritton offers pharmaceutical (prescription drug) malpractice representation in Eastern North Carolina, including Greenville, New Bern,  Rocky Mount, Tarboro, Raleigh and the coastal communities of Morehead City, Jacksonville and Wilmington.

Each day we see advertisements for prescription drugs that include a long list of disclaimers after telling us about the benefits of the drug. This leads us to believe that the pharmaceutical company can’t be challenged. But that’s not the case. Dawson & Albritton, PA can guide you through the complicated pathway of dealing with physicians, pharmacists, health care providers and insurance companies.

It’s important to know that the term “pharmaceutical malpractice” covers a broad range of conditions that can occur if you are a patient, hospitalized or under treatment.. We can help you sort this out.

During our initial consultation, Dawson & Albritton will take the time to listen and recommend the best course of action for you or your loved ones.  The journey can be a long and complicated path but our personal commitment is to be with you every  step of the way, providing clear, professional and timely legal advice on your prescription drug malpractice or negligence lawsuit.

Would you like to know more about pharmaceutical (prescription drug) malpractice? Visit our FAQ  page. Meanwhile, please don’t hesitate to call us at 252-752-2485, or go to our online “Request an Appointment” form to send us a note. Our staff will contact you promptly.

FDA Alert – Acrodose PLus and PL Systems by Haemonetics

ISSUE: Haemonetics recently received reports of low pH readings for platelets stored in the CLX HP bag in certain lots of the Acrodose PLus and PL systems. In some instances the drop in pH is accompanied by a yellow discoloration of the storage bag. Platelets with pH...
Read More

FDA Alert – Coastal Meds Recall of All Products Marketed as Sterile

ISSUE: FDA is alerting health care professionals to a voluntary recall of all non-expired products marketed as sterile made by Coastal Meds due to visible particles in some of the drug vials for injection. BACKGROUND: During FDA’s recent inspection of Coastal Meds,...
Read More

Acyclovir 400mg Tablets by Apace Packaging: Recall – Product Mix-up

Apace Packaging LLC is voluntarily recalling one lot of Acyclovir Tablet, USP, 400mg, 50ct Unit Dose, NDC# 50268-061-15, Lot Number 19900, to the retail level. These products have been recalled due to a product mix-up. A small number of blister cards containing Acyclovir Tablets, 400mg, UD Blister Cards may potentially also include Torsemide, 20mg Tablets.

Read More

Clarithromycin (Biaxin): Drug Safety Communication – Potential Increased Risk of Heart Problems or Death in Patients With Heart Disease

FDA is advising caution before prescribing the antibiotic clarithromycin (Biaxin) to patients with heart disease because of a potential increased risk of heart problems or death that can occur years later. FDAs recommendation is based on a review of the results of a 10-year follow-up study of patients with coronary heart disease from a large clinical trial that first observed this safety issue.

Read More

Labetalol Hydrochloride Injection by Hospira: Recall – Potential For Cracked Glass At Rim Surface Of Vials

ISSUE: Hospira is voluntarily recalling 3 lots of Labetalol Hydrochloride Injection, USP, 100 mg/20 mL Vial (NDC 0409-2267-20), and one lot of Labetalol Hydrochloride Injection, USP, Novaplus (NDC 0409-2267-25) to the hospital/institution level. Hospira, Inc....
Read More

Defibrillation (CRT-Ds) and Implantable Cardiovert-Defibrillators (ICDs) by Medtronic: Class I Recall- Manufacturing Error

Medtronic is recalling certain ICDs and CRT-Ds due to a defect in the manufacturing process. This defect causes an out of specification gas mixture inside the device and may prevent the device from delivering the electrical shock needed to pace a patient’s heartbeat or revive a patient in cardiac arrest. The delay or inability to deliver a shock to a patient in cardiac arrest or pace a patient’s heart whose heartbeat is too slow could result in serious injury and/or death.

Read More

Office Information

204 E. Arlington Blvd.

Suite M

Greenville, NC 27858

Toll Free : 800-261-9681

PH. 252-752-2485